2zm3: Difference between revisions
New page: '''Unreleased structure''' The entry 2zm3 is ON HOLD until Paper Publication Authors: Mayer, S.C., Xu, W., Boschelli, F., Banker, A.L., Di, L., Johnson, M., Kenny, C.H., Krishnamurthy, ... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2zm3.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_2zm3", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_2zm3| PDB=2zm3 | SCENE= }} | |||
'''Complex Structure of Insulin-like Growth Factor Receptor and Isoquinolinedione Inhibitor''' | |||
==Overview== | |||
Insulin-like growth factor receptor (IGF-1R) is a growth factor receptor tyrosine kinase that acts as a critical mediator of cell proliferation and survival. This receptor is over-expressed or activated in tumor cells and is emerging as a novel target in cancer therapy. Efforts in our "Hit to Lead" group have generated a novel series of submicromolar IGF-1R inhibitors based on a isoquinolinedione template originating from a Lance enzyme HTS screen. Chemical triage and parallel synthesis incorporating focused library arrays were instrumental in moving these investigations through the Wyeth exploratory medicinal chemistry process. The strategies, synthesis, and SAR behind this interesting kinase scaffold will be described. | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jun 11 | ==Disease== | ||
Known disease associated with this structure: Intrauterine and postnatal growth retardation OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=147370 147370]] | |||
==About this Structure== | |||
2ZM3 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2ZM3 OCA]. | |||
==Reference== | |||
Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment., Mayer SC, Banker AL, Boschelli F, Di L, Johnson M, Kenny CH, Krishnamurthy G, Kutterer K, Moy F, Petusky S, Ravi M, Tkach D, Tsou HR, Xu W, Bioorg Med Chem Lett. 2008 Jun 15;18(12):3641-5. Epub 2008 Apr 25. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/18501599 18501599] | |||
[[Category: Homo sapiens]] | |||
[[Category: Receptor protein-tyrosine kinase]] | |||
[[Category: Single protein]] | |||
[[Category: Boschelli, F.]] | |||
[[Category: Dwyer, B.]] | |||
[[Category: Johnson, M.]] | |||
[[Category: Mayer, S C.]] | |||
[[Category: Xu, W.]] | |||
[[Category: Atp-binding]] | |||
[[Category: Cleavage on pair of basic residue]] | |||
[[Category: Disease mutation]] | |||
[[Category: Glycoprotein]] | |||
[[Category: Igfr]] | |||
[[Category: Membrane]] | |||
[[Category: Nucleotide-binding]] | |||
[[Category: Phosphoprotein]] | |||
[[Category: Polymorphism]] | |||
[[Category: Protein-inhibitor complex]] | |||
[[Category: Receptor]] | |||
[[Category: Transferase]] | |||
[[Category: Transmembrane]] | |||
[[Category: Tyrosine kinase]] | |||
[[Category: Tyrosine-protein kinase]] | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jun 11 10:45:59 2008'' | |||
Revision as of 10:46, 11 June 2008
Complex Structure of Insulin-like Growth Factor Receptor and Isoquinolinedione Inhibitor
OverviewOverview
Insulin-like growth factor receptor (IGF-1R) is a growth factor receptor tyrosine kinase that acts as a critical mediator of cell proliferation and survival. This receptor is over-expressed or activated in tumor cells and is emerging as a novel target in cancer therapy. Efforts in our "Hit to Lead" group have generated a novel series of submicromolar IGF-1R inhibitors based on a isoquinolinedione template originating from a Lance enzyme HTS screen. Chemical triage and parallel synthesis incorporating focused library arrays were instrumental in moving these investigations through the Wyeth exploratory medicinal chemistry process. The strategies, synthesis, and SAR behind this interesting kinase scaffold will be described.
DiseaseDisease
Known disease associated with this structure: Intrauterine and postnatal growth retardation OMIM:[147370]
About this StructureAbout this Structure
2ZM3 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment., Mayer SC, Banker AL, Boschelli F, Di L, Johnson M, Kenny CH, Krishnamurthy G, Kutterer K, Moy F, Petusky S, Ravi M, Tkach D, Tsou HR, Xu W, Bioorg Med Chem Lett. 2008 Jun 15;18(12):3641-5. Epub 2008 Apr 25. PMID:18501599 Page seeded by OCA on Wed Jun 11 10:45:59 2008
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCA- Pages with broken file links
- Homo sapiens
- Receptor protein-tyrosine kinase
- Single protein
- Boschelli, F.
- Dwyer, B.
- Johnson, M.
- Mayer, S C.
- Xu, W.
- Atp-binding
- Cleavage on pair of basic residue
- Disease mutation
- Glycoprotein
- Igfr
- Membrane
- Nucleotide-binding
- Phosphoprotein
- Polymorphism
- Protein-inhibitor complex
- Receptor
- Transferase
- Transmembrane
- Tyrosine kinase
- Tyrosine-protein kinase